348: Cuts, ousters and drama at the FDA
The Readout Loud
00:00
FDA Leadership Shakeup and Its Impact
This chapter examines a recent address to FDA staff focusing on the 'Make America Healthy Again' agenda and the mixed reactions from employees concerning critical issues like layoffs and vaccine approvals. It highlights the unsettling implications of leadership changes at the FDA, particularly regarding the biotech and pharmaceutical sectors. The discussion also delves into the effects of governmental tariffs and the overall uncertainty enveloping the biopharma industry.
Transcript
Play full episode
